UDCA

https://clinicaltrials.gov/ct2/show/NCT02967250?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=10%2F18%2F2019&lupd_d=14&sort=nwst

STUDY TITLE:
Brain Bioenergetics in Parkinson’s Disease and Response to Repeated Oral UDCA Treatment

DESCRIPTION:
Condition:   Parkinson Disease
Intervention:   Drug: ursodeoxycholic acid
Sponsor:   University of Minnesota
Not yet recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT02967250

FIRST POSTED:
Fri, 18 Nov 2016 12:00:00 EST

LAST UPDATE POSTED:
11/01/19 08:39AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT02967250?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=10%2F18%2F2019&lupd_d=14&sort=nwst

https://clinicaltrials.gov/ct2/show/NCT03840005?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F28%2F2019&lupd_d=14&sort=nwst

STUDY TITLE:
Trial of Ursodeoxycholic Acid (UDCA) for Parkinson’s Disease: The “UP” Study

DESCRIPTION:
Condition:   Parkinson’s Disease
Intervention:   Drug: Ursonorm
Sponsors:   Sheffield Teaching Hospitals NHS Foundation Trust;   JP Moulton Charitable Foundation;   PRO.MED.CS Praha a.s.;   Clinical Trials Research Unit, University of Sheffield
Recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT03840005

FIRST POSTED:
Fri, 15 Feb 2019 12:00:00 EST

LAST UPDATE POSTED:
06/11/19 06:55AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03840005?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F28%2F2019&lupd_d=14&sort=nwst